We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
You must tell DVLA if you have been fitted with a pacemaker - download the correct form to let them know
It's illegal to drive if you're unfit to do so because you're on legal or illegal drugs, or you have certain levels of drugs or medicine in your blood
Advice for medical professionals to follow when assessing drivers with psychiatric disorders.
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
This guidance describes case definitions to inform testing and reporting of suspected mpox cases.
Find out about applying for the Spirit Drinks Verification Scheme, how to submit brand information, fees and making sure your production process is compliant.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Population screening programmes can cause harms as well as benefits, which need to be weighed up by the UK National Screening Committee (UK NSC).
Information for British nationals who are victims of rape and sexual assault in Niue.
Advice and guidance on the health needs of migrant patients from Argentina for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Barbados for healthcare practitioners.
Licence and registration application information for companies that deal in precursor chemicals.
How to use a crossover randomised controlled trial to evaluate your digital health product.
You must get permission to export certain drugs and medicines.
The diagnosis, surveillance and epidemiology of tetanus.
Monitoring significant occupational exposures to HIV, hepatitis B and hepatitis C in healthcare workers, and advising on avoiding injuries.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.